BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 3553328)

  • 1. Measurement of antibody to Jo-1 by ELISA and comparison to enzyme inhibitory activity.
    Targoff IN; Reichlin M
    J Immunol; 1987 May; 138(9):2874-82. PubMed ID: 3553328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoantibodies to aminoacyl-transfer RNA synthetases for isoleucine and glycine. Two additional synthetases are antigenic in myositis.
    Targoff IN
    J Immunol; 1990 Mar; 144(5):1737-43. PubMed ID: 2307838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-Jo-1 antibody levels correlate with disease activity in idiopathic inflammatory myopathy.
    Stone KB; Oddis CV; Fertig N; Katsumata Y; Lucas M; Vogt M; Domsic R; Ascherman DP
    Arthritis Rheum; 2007 Sep; 56(9):3125-31. PubMed ID: 17763431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular localization of the target structures recognized by the anti-Jo-1 antibody: immunofluorescence studies on cultured human myoblasts.
    Shi MH; Tsui FW; Rubin LA
    J Rheumatol; 1991 Feb; 18(2):252-8. PubMed ID: 2023220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epitope mapping of the cloned human autoantigen, histidyl-tRNA synthetase. Analysis of the myositis-associated anti-Jo-1 autoimmune response.
    Ramsden DA; Chen J; Miller FW; Misener V; Bernstein RM; Siminovitch KA; Tsui FW
    J Immunol; 1989 Oct; 143(7):2267-72. PubMed ID: 2476503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purification of mammalian histidyl-tRNA synthetase and its interaction with myositis-specific anti-Jo-1 antibodies.
    Fahoum SK; Yang DC
    Biochemistry; 1987 Sep; 26(18):5871-7. PubMed ID: 3499936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved detection of anti-Jo-1 antibody, a marker for myositis, using purified histidyl-tRNA synthetase.
    Walker EJ; Tymms KE; Webb J; Jeffrey PD
    J Immunol Methods; 1987 Feb; 96(2):149-56. PubMed ID: 3100649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Origin and regulation of a disease-specific autoantibody response. Antigenic epitopes, spectrotype stability, and isotype restriction of anti-Jo-1 autoantibodies.
    Miller FW; Twitty SA; Biswas T; Plotz PH
    J Clin Invest; 1990 Feb; 85(2):468-75. PubMed ID: 1688885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody to threonyl-transfer RNA synthetase in myositis sera.
    Targoff IN; Arnett FC; Reichlin M
    Arthritis Rheum; 1988 Apr; 31(4):515-24. PubMed ID: 3128989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myositis autoantibody inhibits histidyl-tRNA synthetase: a model for autoimmunity.
    Mathews MB; Bernstein RM
    Nature; 1983 Jul 14-20; 304(5922):177-9. PubMed ID: 6866113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rat liver histidyl-tRNA synthetase. Purification and inhibition by the myositis-specific anti-Jo-1 autoantibody.
    Yang DC; Dang CV; Arnett FC
    Biochem Biophys Res Commun; 1984 Apr; 120(1):15-21. PubMed ID: 6712685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical heterogeneity and prognostic features of South Australian patients with anti-synthetase autoantibodies.
    Dugar M; Cox S; Limaye V; Blumbergs P; Roberts-Thomson PJ
    Intern Med J; 2011 Sep; 41(9):674-9. PubMed ID: 20059602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-KS: identification of autoantibodies to asparaginyl-transfer RNA synthetase associated with interstitial lung disease.
    Hirakata M; Suwa A; Nagai S; Kron MA; Trieu EP; Mimori T; Akizuki M; Targoff IN
    J Immunol; 1999 Feb; 162(4):2315-20. PubMed ID: 9973509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patients with non-Jo-1 anti-RNA-synthetase autoantibodies have worse survival than Jo-1 positive patients.
    Hervier B; Devilliers H; Benveniste O
    Ann Rheum Dis; 2013 Jul; 72(7):e18. PubMed ID: 23644669
    [No Abstract]   [Full Text] [Related]  

  • 15. Frequent occurrence of anti-tRNA(His) autoantibodies that recognize a conformational epitope in sera of patients with myositis.
    Brouwer R; Vree Egberts W; Jongen PH; van Engelen BG; van Venrooij WJ
    Arthritis Rheum; 1998 Aug; 41(8):1428-37. PubMed ID: 9704641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Anti-Jo-1 antibody and anti-aminoacyl-tRNA synthetase antibody as a marker autoantibody for myositis].
    Kinoshita M
    Nihon Rinsho; 1990 Feb; 48 Suppl():482-4. PubMed ID: 2355568
    [No Abstract]   [Full Text] [Related]  

  • 17. An enzyme-linked immunosorbent assay for the detection and quantitation of anti-Jo-1 antibody in human serum.
    Biswas T; Miller FW; Takagaki Y; Plotz PH
    J Immunol Methods; 1987 Apr; 98(2):243-8. PubMed ID: 3494784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reaction of anti-OJ autoantibodies with components of the multi-enzyme complex of aminoacyl-tRNA synthetases in addition to isoleucyl-tRNA synthetase.
    Targoff IN; Trieu EP; Miller FW
    J Clin Invest; 1993 Jun; 91(6):2556-64. PubMed ID: 8514867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histidyl-tRNA synthetase, the myositis Jo-1 antigen, is cytoplasmic and unassociated with the cytoskeletal framework.
    Dang CV; LaDuca FM; Bell WR
    Exp Cell Res; 1986 May; 164(1):261-6. PubMed ID: 3956597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intranuclear location of the myositis-specific Jo-1 antigen: hopping histidyl-tRNA synthetase?
    Dang CV
    Arthritis Rheum; 1985 Jul; 28(7):839-40. PubMed ID: 2409986
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.